Detalhe da pesquisa
1.
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model.
Clin Drug Investig
; 44(3): 209-217, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381352
2.
Hospital outcomes and costs for prostate cancer patients with comorbid heart failure by age group: An analysis of the US Nationwide Inpatient Sample.
J Eval Clin Pract
; 29(6): 1016-1024, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256549
3.
Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review.
Expert Rev Pharmacoecon Outcomes Res
; 23(7): 761-771, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306511